HomeMRNS • NASDAQ
add
Marinus Pharmaceuticals Inc
Previous close
$0.54
Day range
$0.54 - $0.54
Year range
$0.22 - $10.50
Market cap
30.03M USD
Avg Volume
2.71M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 8.54M | 770.20% |
Operating expense | 27.55M | 1,599.29% |
Net income | -24.22M | -1,672.78% |
Net profit margin | -283.63 | -103.71% |
Earnings per share | -0.42 | 31.15% |
EBITDA | -20.27M | -1,948.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 42.18M | -76.08% |
Total assets | 63.62M | 922.73% |
Total liabilities | 130.36M | 800.06% |
Total equity | -66.74M | — |
Shares outstanding | 55.19M | — |
Price to book | -0.45 | — |
Return on assets | -69.94% | — |
Return on capital | -136.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.22M | -1,672.78% |
Cash from operations | -19.45M | 22.72% |
Cash from investing | -1.11M | -1,117.49% |
Cash from financing | -1.92M | -757.00% |
Net change in cash | -22.49M | -187,533.33% |
Free cash flow | -11.66M | -6,454.16% |
About
CEO
Founded
1992
Headquarters
Website
Employees
166
